Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis
BMC Medical Genomics, 2018 Background Cellular changes described in human gastroparesis have revealed a role for immune dysregulation, however, a mechanistic understanding of human gastroparesis and the signaling pathways involved are still unclear. Methods Diabetic gastroparetics,
Madhusudan Grover +23 more
doaj +1 more source
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2022 Aim: to analyse the document of the European Society for Neurogastroenterology and Motility consensus on gastroparesis, held in 2020.Key findings. The evaluation of the voting results on the submitted statements of the consensus meeting shows that there ...
A. A. Sheptulin +3 more
doaj +1 more source
Artifact Rejection Methodology Enables Continuous, Noninvasive Measurement of Gastric Myoelectric Activity in Ambulatory Subjects. [PDF]
, 2018 The increasing prevalence of functional and motility gastrointestinal (GI) disorders is at odds with bottlenecks in their diagnosis, treatment, and follow-up.
Coleman, Todd P +5 more
core +2 more sources
Variation in annual volume at a university hospital does not predict mortality for pancreatic resections. [PDF]
, 2008 Annual volume of pancreatic resections has been shown to affect mortality rates, prompting recommendations to regionalize these procedures to high-volume hospitals.
Harris, Hobart W +2 more
core +3 more sources
Post-operative gastroparesis following carbohydrate loading in a diabetic patient
Gynecologic Oncology Reports, 2021 Gastroparesis is a syndrome of delayed gastric emptying associated with nausea, vomiting, and postprandial fullness. Despite multiple etiologies, diabetes is one of the principal causes of gastroparesis. This case report examines a 57 year-old woman with
Jeffrey A. How +2 more
doaj +1 more source
A Wireless Implantable System for Facilitating Gastrointestinal Motility. [PDF]
, 2019 Gastrointestinal (GI) electrical stimulation has been shown in several studies to be a potential treatment option for GI motility disorders. Despite the promising preliminary research progress, however, its clinical applicability and usability are still ...
Dubrovsky, Genia +4 more
core +1 more source
Therapeutic applications of ghrelin agonists in the treatment of gastroparesis [PDF]
, 2015 There remains an unmet need for effective pharmacologic treatments for gastroparesis. Ghrelin is the endogenous ligand for the growth hormone secretagogue receptor and has been shown to regulate energy homeostasis and exert prokinetic effects on ...
Shin, Andrea, Wo, John M.
core +1 more source
Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting [PDF]
, 2013 Background Factors associated with abdominal pain in gastroparesis are incompletely evaluated and comparisons of pain vs other symptoms are limited. This study related pain to clinical factors in gastroparesis and contrasted pain/discomfort‐ with nausea/
Abell, T. L. +15 more
core +1 more source
Drugs in Context, 2023 Background: Gastroparesis is a serious condition that can be caused by diabetes, surgery or infection, or can be idiopathic. When there is no mechanical obstruction, gastroparesis is characterized by delayed stomach emptying. Itopride, a prokinetic drug,
Adil Ramzan +28 more
doaj +1 more source
Noninvasive ¹³C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis [PDF]
, 1999 Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive loss of motor neurons. However, ALS has been recognized to also involve non-motor systems.
Folwaczny, Christian +6 more
core +1 more source